FINWIRES · TerminalLIVE
FINWIRES

UBS Upgrades Zimmer Biomet Holdings to Buy From Sell, Adjusts Price Target to $115 From $89

By

Zimmer Biomet Holdings (ZBH) has an average rating of overweight and mean price target of $96.95, according to analysts polled by FactSet.

Price: $97.15, Change: $+5.08, Percent Change: +5.52%

What else is happening in Research?